Update: Influenza activity — United States, September 28–December 6, 2014

Morbidity and Mortality Weekly Report

Volumn 63, Issue 50, 2014, Pages 1189-1194

  Rolfes, Melissa ^a   Blanton, Lenee ^a   Brammer, Lynnette ^a   Smith, Sophie ^a   Mustaquim, Desiree ^a   Steffens, Craig ^a   Cohen, Jessica ^a   Leon, Michelle ^a   Chaves, Sandra S ^a   Abd Elal, Anwar Isa ^a   Gubareva, Larisa ^a   Hall, Henrietta ^a   Wallis, Teresa ^a   Villanueva, Julie ^a   Xu, Xiyan ^a   Bresee, Joseph ^a   Cox, Nancy ^a   Finelli, Lyn ^a  

^a NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEALTH SURVEY; HUMAN; INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS A H3N2; INFLUENZA VIRUS B; INFLUENZA, HUMAN; ISOLATION AND PURIFICATION; SEASON; UNITED STATES;

HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA B VIRUS; INFLUENZA, HUMAN; POPULATION SURVEILLANCE; SEASONS; UNITED STATES;

EID: 84919399861     PISSN: 01492195     EISSN: 1545861X     Source Type: Journal    
DOI: None     Document Type: Article

References (4)

1. Blanton L, Brammer L, Smith S, et al. Update: influenza activity—United States and worldwide, May 18–September 20, 2014. MMWR Morb Mortal Wkly Rep 2014;63:861–4.
2. Grohskopf LA, Olsen SJ, Sokolow LZ, et al. Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP)—United States, 2014–15 influenza season. MMWR Morb Mortal Wkly Rep 2014;63:691–7.
3. Neuzil KM, Jackson LA, Nelson J, et al. Immunogenicity and reactogenicity of 1 versus 2 doses of trivalent inactivated influenza vaccine in vaccine-naive 5–8-year-old children. J Infect Dis. 2006;194:1032–9.
4. Fiore AE, Fry A, Shay D, Gubareva L, Bresee JS, Uyeki TM. Antiviral agents for the treatment and chemoprophylaxis of influenza—recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2011;60(No. RR-1).